Mapping pathology spread in alzheimer's disease with integrative network approaches
Active Grant Awarded
- Award ID
- R01AG103025
- Recipient
-
Trustees Of Indiana University UEI SHHBRBAPSM35
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $317,000
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date 4% complete
- Place of performance
- Indianapolis, IN 46202, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services, National Institutes of Health, National Institute on Aging awarded Trustees of Indiana University, doing business as Indiana University Indianapolis, $317,000 in obligated funding under Grant R01AG103025 on September 9, 2026, through Assistance Listing 93.866, Aging Research. The grant funds a project titled "Mapping Pathology Spread in Alzheimer's Disease with Integrative Network Approaches." The project integrates longitudinal amyloid-beta and tau PET imaging with a multilayer connectome derived from MRI, alongside spatial transcriptomics (whole-brain gene expression profiles) and PET-derived receptor density maps. The recipient will develop an analytic framework that combines structural and functional connectivity into unified network measures, then test hypotheses on connectome changes linked to Alzheimer's biomarkers, prediction of personalized biomarker and cognitive trajectories, and generalization of connectome-derived biomarkers across independent cohorts. The period of performance ends May 31, 2031, and work is performed in Indianapolis, Indiana. The assistance type is grant.
Description
- Abstract
- Alzheimer's disease (ad) is a prevalent and disabling neurodegenerative disorder, characterized by abnormal accumulation of amyloid-Β (AΒ) plaques and TAU neurofibrillary tangles in the brain. These neuropathological features attack the integrity of brain networks (the connectome), leading to severe cognitive and functional impairments. Despite substantial progress, a critical GAP remains in understanding how AΒ and TAU spread through structural and functional connectivity (SC/FC) as measured by diffusion and functional MRI. Moreover, most connectome studies in ad are cross-sectional, limiting insights into individual trajectories, developmental patterns, and causal mechanisms. This project will, for the first time, provide a comprehensive analysis of ad pathology propagation by integrating longitudinal pathophysiological biomarkers (AΒ and TAU pet imaging) with multilayer connectome (derived from MRI), alongside static biological features, such as spatial transcriptomics (whole-brain gene expression profiles) and neurotransmission (pet-derived receptor density maps). We will develop an innovative analytic framework that integrates SC and FC into a multilayer structural-functional connectome, enabling the generation of unified network measures that jointly captures information of brain structure and function. We hypothesize that: 1) cognition-related multilayer connectome changes are linked to ad biomarkers; 2) combining multilayer connectivity with regional biological features can model spatial patterns and dynamic interactions of AΒ/TAU spread, brain atrophy due to neurodegeneration, and intervention strategies; 3) multilayer metrics enable accurate prediction of personalized AΒ/TAU and cognitive trajectories; and 4) connectome-derived biomarkers will generalize across independent cohorts. To test these hypotheses, we will leverage existing multimodal imaging and clinical data from three independent ad cohorts: the imas, adni, and kbase. Briefly, aim 1 will identify multilayer connectome mechanisms linking network disruption, AΒ/TAU burden, and domain-specific cognitive dysfunction in imas. Aim 2 will develop novel connectome-based epidemic spreading models that integrate multilayer connectivity, gene expression profiles and neurotransmitter signaling to simulate spatial dynamics of AΒ/TAU spread and their mutual interactions, brain atrophy, and intervention effects. Aim 3 will build personalized prediction models by integrating longitudinal connectome data in adni to predict individualized AΒ/TAU accumulations and cognitive decline. An exploratory aim 4 will test the robustness and reproducibility of findings across imas, adni, and kbase using cross-validation and external validation. In SUM, this project will deliver mechanistic insights (aim 1), computational models (aim 2), predictive tools (aim 3), and validated biomarkers (aim 4) to accelerate individualized biomarker discovery and therapeutic target identification, ultimately advancing precision medicine in ad.
Quick answers
Who received award R01AG103025?
R01AG103025 was awarded to Trustees Of Indiana University by National Institute on Aging (National Institutes of Health) on September 9, 2026.
How much is award R01AG103025 worth?
$317,000 has been obligated on R01AG103025.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award